Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 3D SYSTEMS CORPDDD · Entity 5407 | Director | May 14, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
3D SYSTEMS CORP
Report date May 14, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 395,178 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 45,731 · Balance 395,178 F1: Inadvertently filed late due to administrative error. F2: Shares were awarded to the Reporting Person under the Issuer's 2015 Incentive Plan pursuant to the Non-Employee Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Inadvertently filed late due to administrative error.
F2: Shares were awarded to the Reporting Person under the Issuer's 2015 Incentive Plan pursuant to the Non-Employee Director Compensation Policy.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
American Renal Associates Holdings, Inc.
Report date January 25, 2021 · Filed January 26, 2021
Section 16 reporting ended · disclosed 2021-01-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-01-25 transaction · row 1
1 source rowRow 1 · 2021-01-25 · Disposition to issuer · Disposed 49,435 · Balance 0 F1: On January 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 1, 2020, by and among the Issuer, IRC Superman Midco, LLC ("IRC") and Superman Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger, each share of common stock of the Issuer was cancelled and converted into the right to receive $11.50 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested share of restricted stock, including performance-based restricted stock, automatically vested and was converted in the right to receive the Per Share Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2021-01-25 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-01-25 · Disposition to issuer · Disposed 18,320 · Balance 0 F1: On January 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 1, 2020, by and among the Issuer, IRC Superman Midco, LLC ("IRC") and Superman Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger, each share of common stock of the Issuer was cancelled and converted into the right to receive $11.50 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested share of restricted stock, including performance-based restricted stock, automatically vested and was converted in the right to receive the Per Share Merger Consideration. F2: Shares held by limited partnership for the benefit of the Reporting Person's family. The Reporting Person disclaims beneficial ownership of the shares held by such limited liability companies, except to the extent of his pecuniary interest therein. The filing of this statement by the Reporting Person shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, such Reporting Person is the beneficial owners of the securities reported herein. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 1, 2020, by and among the Issuer, IRC Superman Midco, LLC ("IRC") and Superman Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger, each share of common stock of the Issuer was cancelled and converted into the right to receive $11.50 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested share of restricted stock, including performance-based restricted stock, automatically vested and was converted in the right to receive the Per Share Merger Consideration.
F2: Shares held by limited partnership for the benefit of the Reporting Person's family. The Reporting Person disclaims beneficial ownership of the shares held by such limited liability companies, except to the extent of his pecuniary interest therein. The filing of this statement by the Reporting Person shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, such Reporting Person is the beneficial owners of the securities reported herein.
LUMINEX CORP
Report date July 14, 2021 · Filed July 15, 2021
Section 16 reporting ended · disclosed 2021-07-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,162 |
Reported balance
After 2021-07-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-07-14 · Disposition to issuer · Disposed 79,204 · Balance 108,162 F1: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share. F2: This total includes 1560 dividend equivalent shares acquired from the Issuer as follows: 263 shares on 07/09/20, 390 shares on 10/15/20, 356 shares on 01/14/21, 270 shares on 04/15/21, and 281 shares on 07/08/21. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-07-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-07-14 · Disposition to issuer · Disposed 108,162 · Balance 0 F3: Disposed of pursuant to the Merger Agreement, whereby unvested restricted stock units ("Company RSUs") which were outstanding as of immediately prior to the Effective Time fully vested, and each Company RSU that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share.
F2: This total includes 1560 dividend equivalent shares acquired from the Issuer as follows: 263 shares on 07/09/20, 390 shares on 10/15/20, 356 shares on 01/14/21, 270 shares on 04/15/21, and 281 shares on 07/08/21.
F3: Disposed of pursuant to the Merger Agreement, whereby unvested restricted stock units ("Company RSUs") which were outstanding as of immediately prior to the Effective Time fully vested, and each Company RSU that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 29, 2026 20:35 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 45,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001120226-26-000001 · wk-form4_1780086912.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,178 F1 · date: Inadvertently filed late due to administrative error. F2 · shares: Shares were awarded to the Reporting Person under the Issuer's 2015 Incentive Plan pursuant to the Non-Employee Director Compensation Policy. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:55 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 29,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031371 · wk-form4_1749848107.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,447 F1 · shares: Shares were awarded to the Reporting Person under the Issuer's 2015 Incentive Plan pursuant to the Non-Employee Director Compensation Policy. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:57 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 63,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-039350 · wk-form4_1725482539.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,378 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| November 28, 2023 Filed Nov 29, 2023 21:09 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | PurchaseCommon Stock | 50,000 | $5.30 | $265,000.00 |
DisclosureSEC source: 0001209191-23-056893 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,294 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.29 to $5.3176, inclusive. The reporting person undertakes to provide to 3D Systems Corporation, any security holder of 3D Systems Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 of this Form 4. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 22:44 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | PurchaseCommon Stock | 50,000 | $4.57 | $228,400.00 |
DisclosureSEC source: 0001209191-23-056521 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,294 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.6417 to $4.6732, inclusive. The reporting person undertakes to provide to 3D Systems Corporation, any security holder of 3D Systems Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 of this Form 4. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:15 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 18,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030618 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,294 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:43 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 15,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032222 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,200 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 16:01 UTC | LUMINEX CORP LMNX · Entity 137318 | Disposition to issuerCommon Stock | 108,162 | $37.00 | $4,001,994.00 |
DisclosureSEC source: 0001033905-21-000059 · wf-form4_162637925151844.xml · nonDerivative · entry 2 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: Disposed of pursuant to the Merger Agreement, whereby unvested restricted stock units ("Company RSUs") which were outstanding as of immediately prior to the Effective Time fully vested, and each Company RSU that was outstanding immediately prior to the Effective Time was canceled at the Effective Time, in exchange for cash payments in the amount of $37.00 per share (without interest and subject to deduction for any required withholding taxes). Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 16:01 UTC | LUMINEX CORP LMNX · Entity 137318 | Disposition to issuerCommon Stock | 79,204 | $37.00 | $2,930,548.00 |
DisclosureSEC source: 0001033905-21-000059 · wf-form4_162637925151844.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,162 F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger, by and among DiaSorin S.p.A., Diagonal Subsidiary Inc. and Luminex Corporation (the "Issuer"), dated April 11, 2021 (the "Merger Agreement"), whereby each outstanding share of the Issuer's common stock was cancelled at the effective time (the "Effective Time") of the merger (the "Merger") and converted into the right to receive a cash payment of $37.00 per share. F2 · balance_after: This total includes 1560 dividend equivalent shares acquired from the Issuer as follows: 263 shares on 07/09/20, 390 shares on 10/15/20, 356 shares on 01/14/21, 270 shares on 04/15/21, and 281 shares on 07/08/21. Read SEC document |
| May 18, 2021 Filed May 19, 2021 21:37 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 6,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034080 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,185 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:46 UTC | American Renal Associates Holdings, Inc. ARA · Entity 143402 | Disposition to issuerCommon Stock | 18,320 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-002181 · form4.xml · nonDerivative · entry 2 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · price: On January 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 1, 2020, by and among the Issuer, IRC Superman Midco, LLC ("IRC") and Superman Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger, each share of common stock of the Issuer was cancelled and converted into the right to receive $11.50 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested share of restricted stock, including performance-based restricted stock, automatically vested and was converted in the right to receive the Per Share Merger Consideration. F2 · ownership.nature: Shares held by limited partnership for the benefit of the Reporting Person's family. The Reporting Person disclaims beneficial ownership of the shares held by such limited liability companies, except to the extent of his pecuniary interest therein. The filing of this statement by the Reporting Person shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, such Reporting Person is the beneficial owners of the securities reported herein. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:46 UTC | American Renal Associates Holdings, Inc. ARA · Entity 143402 | Disposition to issuerCommon Stock | 49,435 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-002181 · form4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On January 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 1, 2020, by and among the Issuer, IRC Superman Midco, LLC ("IRC") and Superman Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer with the Issuer surviving as a wholly owned subsidiary of IRC (the "Merger"). Upon consummation of the Merger, each share of common stock of the Issuer was cancelled and converted into the right to receive $11.50 per share in cash (the "Per Share Merger Consideration"). In addition, each unvested share of restricted stock, including performance-based restricted stock, automatically vested and was converted in the right to receive the Per Share Merger Consideration. Read SEC document |
| September 21, 2020 Filed Sep 22, 2020 23:12 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 15,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-051569 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,178 F1 · shares: Shares were awarded to the Reporting Person under the Issuer's 2015 Incentive Plan pursuant to the Non-Employee Director Compensation Policy. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 15:44 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 5,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-20-000072 · wf-form4_159121343096120.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,806 F1 · balance_after: This total includes 1,305 dividend shares acquired as follows: 270 shares on 07/11/19, 402 shares on 10/17/19, 348 shares on 01/15/20, and 285 shares on 04/09/20. Read SEC document |
| May 19, 2020 Filed Jun 8, 2020 23:36 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035134 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,969 F1 · shares: Shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 20:09 UTC | American Renal Associates Holdings, Inc. ARA · Entity 143402 | GrantCommon Stock | 17,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001498068-20-000050 · wf-form4_158464853019182.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,435 F1 · kind: Reflects a grant of restricted stock that vests on March 18, 2021. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 21:08 UTC | American Renal Associates Holdings, Inc. ARA · Entity 143402 | GrantCommon Stock | 12,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001498068-19-000095 · wf-form4_157653047390452.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,284 F1 · kind: Reflects a grant of restricted stock that vests on March 9, 2020. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:31 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 11,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-032072 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,969 F1 · price: A total of 11,455 shares were awarded to the Reporting Person. Of those shares, 2,323 shares were awarded to the Reporting Person pursuant to the 2004 Restricted Stock Plan for Non-Employee Directors, and the Reporting Person purchased these shares at par value, or $0.001 per share; and 9,132 shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan and had no purchase price. Read SEC document |
| May 17, 2019 Filed May 20, 2019 18:37 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 8,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-19-000049 · wf-form4_155839184155524.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,848 F1 · balance_after: This total includes 754 dividend shares acquired as follows: 156 shares on 07/13/18, 184 shares on 10/12/18, 202 shares on 01/10/19, and 212 shares on 04/11/19. Read SEC document |
| May 17, 2018 Filed Jun 1, 2018 18:33 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 7,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-18-000073 · wf-form4_152789239854126.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,787 F1 · balance_after: This total includes 213 dividend shares from 07/14/17, 218 dividend shares from 10/13/17, 219 dividend shares from 01/12/18, 211 dividend shares from 04/13/18 and a grant of 6,705 shares on 05/18/18. Read SEC document |
| May 15, 2018 Filed May 16, 2018 20:20 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 7,758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-030494 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,514 F1 · price: A total of 7,758 shares were awarded to the Reporting Person. Of those shares, 3,000 shares were awarded to the Reporting Person pursuant to the 2004 Restricted Stock Plan for Non-Employee Directors, and the Reporting Person purchased these shares at par value, or $0.001 per share; and 4,758 shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan and had no purchase price. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 00:44 UTC | American Renal Associates Holdings, Inc. ARA · Entity 143402 | GrantCommon Stock | 5,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001498068-18-000043 · wf-form4_152159306469095.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,526 F1 · shares: Reflects a grant of restricted stock that vests on March 19, 2019. Read SEC document |
| May 18, 2017 Filed May 22, 2017 15:12 UTC | LUMINEX CORP LMNX · Entity 137318 | GrantCommon Stock | 8,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001033905-17-000060 · wf-form4_149548031976500.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,221 F1 · balance_after: This total includes 223 dividend shares from April 14, 2017 payable date, and a grant of 8,988 shares on May 18,2017. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:17 UTC | 3D SYSTEMS CORP DDD · Entity 5407 | GrantCommon Stock | 4,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-033049 · doc4.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,756 F1 · price: A total of 4,290 shares were awarded to the Reporting Person. Of those shares, 3,000 shares were awarded to the Reporting Person pursuant to the 2004 Restricted Stock Plan for Non-Employee Directors, and the Reporting Person purchased these shares at par value, or $0.001 per share; and 1,290 shares were awarded to the Reporting Person pursuant to the Issuer's 2015 Incentive Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 21:31 UTC | American Renal Associates Holdings, Inc. ARA · Entity 143402 | GrantCommon Stock | 13,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-004507 · edgar.xml · nonDerivative · entry 1 ERICKSON THOMAS W · CIK 0001120226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,801 F1 · kind: Reflects a grant of restricted stock that vests as follows: (a) 6,326 shares immediately vested on the grant date, March 10, 2017, and (b) 7,475 shares vest on March 10, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.